HKD 1.16
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 641.51 Million CNY | -16.32% |
2022 | 766.67 Million CNY | 13.52% |
2021 | 675.36 Million CNY | 23.79% |
2020 | 545.55 Million CNY | 4.36% |
2019 | 522.75 Million CNY | -12.15% |
2018 | 595.02 Million CNY | 5.96% |
2017 | 561.54 Million CNY | 9.79% |
2016 | 511.47 Million CNY | -10.17% |
2015 | 569.38 Million CNY | 23.8% |
2014 | 459.91 Million CNY | 14.05% |
2013 | 403.24 Million CNY | 24.31% |
2012 | 324.39 Million CNY | -10.57% |
2011 | 362.75 Million CNY | -3.56% |
2010 | 376.15 Million CNY | 14.66% |
2009 | 328.05 Million CNY | 27.81% |
2008 | 256.66 Million CNY | 7.17% |
2007 | 239.5 Million CNY | 30.16% |
2006 | 184 Million CNY | -14.51% |
2005 | 215.23 Million CNY | 11.71% |
2004 | 192.67 Million CNY | -6.42% |
2003 | 205.9 Million CNY | 19.5% |
2002 | 172.3 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 FY | 641.51 Million CNY | -16.32% |
2023 Q2 | 356.04 Million CNY | 0.0% |
2023 Q4 | 272.43 Million CNY | 0.0% |
2022 FY | 766.67 Million CNY | 13.52% |
2022 Q4 | 378.32 Million CNY | 0.0% |
2022 Q2 | 388.35 Million CNY | 0.0% |
2021 Q2 | 364.07 Million CNY | 0.0% |
2021 FY | 675.36 Million CNY | 23.79% |
2021 Q4 | 311.29 Million CNY | 0.0% |
2020 Q2 | 270.53 Million CNY | 0.0% |
2020 Q4 | 275.01 Million CNY | 0.0% |
2020 FY | 545.55 Million CNY | 4.36% |
2019 Q2 | 295.07 Million CNY | 0.0% |
2019 Q4 | 227.67 Million CNY | 0.0% |
2019 FY | 522.75 Million CNY | -12.15% |
2018 Q2 | 312.67 Million CNY | 0.0% |
2018 Q4 | 282.35 Million CNY | 0.0% |
2018 FY | 595.02 Million CNY | 5.96% |
2017 Q2 | 283.29 Million CNY | 0.0% |
2017 Q4 | 278.25 Million CNY | 0.0% |
2017 FY | 561.54 Million CNY | 9.79% |
2016 Q2 | 255.7 Million CNY | 0.0% |
2016 FY | 511.47 Million CNY | -10.17% |
2016 Q4 | 255.77 Million CNY | 0.0% |
2015 Q4 | 264.94 Million CNY | 0.0% |
2015 FY | 569.38 Million CNY | 23.8% |
2015 Q2 | 304.44 Million CNY | 0.0% |
2014 FY | 459.91 Million CNY | 14.05% |
2014 Q2 | 235.32 Million CNY | 0.0% |
2014 Q4 | 224.59 Million CNY | 0.0% |
2013 FY | 403.24 Million CNY | 24.31% |
2013 Q2 | 188.3 Million CNY | 0.0% |
2013 Q4 | 214.94 Million CNY | 0.0% |
2012 FY | 324.39 Million CNY | -10.57% |
2012 Q3 | 81.09 Million CNY | 0.0% |
2012 Q1 | 81.09 Million CNY | 0.0% |
2012 Q4 | 100.81 Million CNY | 24.31% |
2012 Q2 | 81.09 Million CNY | 0.0% |
2011 FY | 362.75 Million CNY | -3.56% |
2011 Q2 | 90.68 Million CNY | 0.0% |
2011 Q3 | 90.68 Million CNY | 0.0% |
2011 Q4 | 81.09 Million CNY | -10.57% |
2011 Q1 | 90.68 Million CNY | 0.0% |
2010 Q4 | 90.68 Million CNY | -3.56% |
2010 Q2 | 94.03 Million CNY | 0.0% |
2010 Q1 | 94.03 Million CNY | 0.0% |
2010 Q3 | 94.03 Million CNY | 0.0% |
2010 FY | 376.15 Million CNY | 14.66% |
2009 Q3 | 82.01 Million CNY | 0.0% |
2009 Q4 | 94.03 Million CNY | 14.66% |
2009 FY | 328.05 Million CNY | 27.81% |
2009 Q2 | 82.01 Million CNY | 0.0% |
2009 Q1 | 82.01 Million CNY | 0.0% |
2008 Q4 | 82.01 Million CNY | 27.81% |
2008 FY | 256.66 Million CNY | 7.17% |
2008 Q1 | 64.16 Million CNY | 0.0% |
2008 Q2 | 64.16 Million CNY | 0.0% |
2008 Q3 | 64.16 Million CNY | 0.0% |
2007 Q4 | 64.16 Million CNY | 7.17% |
2007 FY | 239.5 Million CNY | 30.16% |
2007 Q2 | 59.87 Million CNY | 0.0% |
2007 Q3 | 59.87 Million CNY | 0.0% |
2007 Q1 | 59.87 Million CNY | 0.0% |
2006 FY | 184 Million CNY | -14.51% |
2006 Q2 | 46 Million CNY | 0.0% |
2006 Q3 | 46 Million CNY | 0.0% |
2006 Q4 | 59.87 Million CNY | 30.16% |
2006 Q1 | 46 Million CNY | 0.0% |
2005 FY | 215.23 Million CNY | 11.71% |
2005 Q1 | 53.8 Million CNY | 0.0% |
2005 Q2 | 53.8 Million CNY | 0.0% |
2005 Q3 | 53.8 Million CNY | 0.0% |
2005 Q4 | 46 Million CNY | -14.51% |
2004 Q3 | 48.16 Million CNY | 0.0% |
2004 Q4 | 53.8 Million CNY | 11.71% |
2004 Q1 | 48.16 Million CNY | 0.0% |
2004 Q2 | 48.16 Million CNY | 0.0% |
2004 FY | 192.67 Million CNY | -6.42% |
2003 Q2 | 51.47 Million CNY | 0.0% |
2003 Q1 | 51.47 Million CNY | 0.0% |
2003 FY | 205.9 Million CNY | 19.5% |
2003 Q4 | 48.16 Million CNY | -6.42% |
2003 Q3 | 51.47 Million CNY | 0.0% |
2002 Q2 | 43.07 Million CNY | 0.0% |
2002 FY | 172.3 Million CNY | 0.0% |
2002 Q3 | 43.07 Million CNY | 0.0% |
2002 Q1 | 43.07 Million CNY | 0.0% |
2002 Q4 | 51.47 Million CNY | 19.5% |
2001 Q4 | 43.07 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pak Fah Yeow International Limited | 167.43 Million HKD | -283.143% |
Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 90.167% |
Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -2129.122% |
Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -62.487% |
Qianhai Health Holdings Limited | -35.6 Million HKD | 1901.868% |
Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -16.362% |
Essex Bio-Technology Limited | 1.53 Billion HKD | 58.324% |
Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -36.119% |
PuraPharm Corporation Limited | 216.62 Million HKD | -196.137% |
SSY Group Limited | 3.48 Billion HKD | 81.614% |
JBM (Healthcare) Limited | 319.41 Million HKD | -100.841% |
Jacobson Pharma Corporation Limited | 620.47 Million HKD | -3.392% |
China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 98.521% |